Gambia vs Mali: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%)
Gambia
82.0%
in 2025
Mali
68.0%
in 2025
Gambia rank
3rd
Mali rank
6th
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) over time
- Gambia
- Mali
How they compare
Gambia currently reports 82.0% against 68.0% in Mali, a difference of 14.0%.
That makes Gambia's figure about 1.2 times Mali's.
The two have swapped places 3 times across 10 shared years of data; in 2016 it was Mali ahead.
Gambia ranks 3rd and Mali ranks 6th of 26 countries.
Across the 2 decades both report, Gambia averaged higher in 1 and Mali in 1.
Head to head by decade
| Decade | Gambia | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8.8% | 44.8% | 36.0% | Mali |
| 2020s | 75.3% | 66.5% | 8.8% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher meningococcal a conjugate (menga) vaccine immunization coverage (%), Gambia or Mali?
- Gambia, at 82.0% against 68.0% in Mali as of 2025.
- What is the difference in meningococcal a conjugate (menga) vaccine immunization coverage (%) between Gambia and Mali?
- 14.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Mali?
- 10 years are reported by both, from 2016 to 2025.
- How do Gambia and Mali rank globally for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
- Gambia ranks 3rd and Mali ranks 6th of 26 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.